Achievement of Cure with Gefitinib in Advanced Lung Adenocarcinoma Harboring an Activating EGFR Mutation: A Case Report

Publisher： Karger

E-ISSN： 1662-6575|9|3|565-567

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.9, Iss.3, 2016-10, pp. : 565-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Near Total Regression of Diffuse Brain Metastases in Adenocarcinoma of the Lung with an EGFR Exon 19 Mutation: A Case Report and Review of the Literature

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-09 ,pp. : 445-451

Karger

Access to resources Recommend Favorite

Afatinib, Erlotinib and Gefitinib in the First-Line Therapy of EGFR Mutation-Positive Lung Adenocarcinoma: A Review

By  

Oncology Research and Treatment, Vol. 36, Iss. 9, 2013-08 ,pp. : 510-518

Karger

Access to resources Recommend Favorite

Cytomorphological identification of advanced pulmonary adenocarcinoma harboring KRAS mutation in lymph node fine‐needle aspiration specimens: Comparative investigation of adenocarcinoma with KRAS and EGFR mutations

By  

DIAGNOSTIC CYTOPATHOLOGY, Vol. 43, Iss. 7, 2015-07 ,pp. : 539-544

John Wiley & Sons Inc

Access to resources Recommend Favorite

Down-Staging of EGFR Mutation-Positive Advanced Lung Carcinoma with Gefitinib Followed by Surgical Intervention: Follow-Up of Two Cases

By  

Oncology Research and Treatment, Vol. 32, Iss. 11, 2009-10 ,pp. : 674-677

Karger

Access to resources Recommend Favorite

EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-03 ,pp. : 164-168

Karger

Access to resources Recommend Favorite